Circulating soluble IL-6 receptor associates with plaque inflammation but not with atherosclerosis severity and cardiovascular risk

CONCLUSIONS: Our findings show that sIL-6R is a poor marker of CVD risk and associated vascular changes. However, the observation that sIL-6R reflects plaque inflammation highlights the complexity of the role of IL-6 in CVD.PMID:37634789 | DOI:10.1016/j.vph.2023.107214

Source: Vascular Pharmacology - August 27, 2023 Category: Drugs & Pharmacology Authors: Andreas Edsfeldt Isabel Gon çalves Isa Vigren Anja Jovanovi ć Gunnar Engstr öm Angela C Shore Andrea Natali Faisel Khan Jan Nilsson Source Type: research